NCT05753501 2026-06-02Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesAbbViePhase 1 Active not recruiting135 enrolled